The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Subjects

NCT04422496 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

73

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-alcoholic Fatty Liver Disease
Non-alcoholic Steatohepatitis

Interventions

DRUG: HEC96719

Sponsor

Sunshine Lake Pharma Co., Ltd.